LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
89.57 84.90 1628 7494 0.2172 0.5792
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
89.57 84.90 6216 7494 0.8294 0.9430
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
91.27 84.90 1402 7420 0.1889 0.5446
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
91.27 84.90 6769 7420 0.9122 0.9717
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
91.27 84.90 6558 7420 0.8838 0.9621
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
91.27 84.90 6580 7420 0.8868 0.9631
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
91.27 84.90 1688 7420 0.2275 0.5897
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
91.27 84.90 6530 7420 0.8800 0.9608
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
92.98 84.90 1452 7257 0.2001 0.5565
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
92.98 84.90 6992 7257 0.9634 0.9884
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
92.98 84.90 6714 7257 0.9251 0.9759
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
92.98 84.90 6758 7257 0.9312 0.9779
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
92.98 84.90 1783 7257 0.2457 0.6071
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
92.98 84.90 6711 7257 0.9247 0.9758
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
94.68 84.90 1585 7000 0.2264 0.5838
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
94.68 84.90 7297 7000 1.0424 1.0131
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
94.68 84.90 6888 7000 0.9840 0.9949
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
94.68 84.90 6928 7000 0.9897 0.9967
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
94.68 84.90 1887 7000 0.2696 0.6278
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
94.68 84.90 6928 7000 0.9897 0.9967
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.0056667
2.66 84.90 1 285 0.0035 -0.9209
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
2.66 84.90 544 285 1.9038 1.8889
MN20160318_Q02
C11
MCF 10A-H2B-mCherry Trametinib
0.0056667
2.66 84.90 1 285 0.0035 -0.9209
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
2.66 84.90 517 285 1.8093 1.8061
MN20160318_Q02
F12
MCF 10A-H2B-mCherry Trametinib
0.0056667
4.36 84.90 1 322 0.0031 -0.9004
MN20160318_Q02
C11